Lilian T Gien
ECOG-ACRIN Cancer Research Group · NRG Oncology
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Lilian T Gien as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:22 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06390826 · Testing Sunitinib as Potentially Targeted Treatment in Cancers With cKIT Genetic Changes (MATCH - Subprotocol V)National Cancer Institute (NCI) · active not recruiting · Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Refractory Lymphoma · principal investigator
- Ph2NCT03602586 · Testing Whether the Combination of Two Immunotherapy Drugs Have Activity in Recurrent or Persistent Clear Cell Ovarian CancerNational Cancer Institute (NCI) · completed · Malignant Ovarian Clear Cell Tumor, Recurrent Ovarian Carcinoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:22 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- ECOG-ACRIN Network Group Operations CenterU10CA180820 · NCI · ECOG-ACRIN MEDICAL RESEARCH FOUNDATION · PI Peter J ODwyer, MITCHELL D. SCHNALL · fiscal years 2014 to 2026Named on NCT06390826
- NRG Oncology Network Group Operations CenterU10CA180868 · NCI · NRG ONCOLOGY FOUNDATION, INC. · PI Quynh-Thu Xuan Le, ROBERT S. MANNEL, NORMAN WOLMARK · fiscal years 2014 to 2026Named on NCT03602586
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 09:22 UTC. The ranking covers the 200 most relevant of 11 PubMed records, and a shared surname and initials can bring in a namesake. All 11 on PubMed
- Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer.N Engl J Med · 2023664 citationsRCR 59.6
- 266 citationsRCR 12.4
- 70 citationsRCR 13.5
- Surgical outcome of robotic surgery in morbidly obese patient with endometrial cancer compared to laparotomy.Int J Gynecol Cancer · 201267 citationsRCR 2.5
- 25 citationsRCR 2.0
- Phase II trial of pembrolizumab and epacadostat in recurrent clear cell carcinoma of the ovary: An NRG oncology study GY016.Gynecol Oncol · 202419 citationsRCR 2.1
- 17 citationsRCR 2.2
- Is adjuvant chemotherapy beneficial for surgical stage I ovarian clear cell carcinoma?Gynecol Oncol · 201714 citationsRCR 0.4
- Dual mechanical and pharmacological thromboprophylaxis decreases risk of pulmonary embolus after laparotomy for gynecologic malignancies.Int J Gynecol Cancer · 20224 citationsRCR 0.5